Beyond tumor necrosis factor and interleukin-12/23: The rise of interleukin-23 inhibitors in inflammatory bowel disease management
Author:
Catarina Costa,Nurulamin M. Noor,Maria Manuela Estevinho
Publication:
Current Opinion in Pharmacology
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.